Trivascular
Merged
Embrace the evidence
- Headquarters
- Santa Rosa, California
- Employees
- 201–500
- Founded
- 1999
- Business Model
- B2B
- Website
- trivascular.com
- Total Funding
- $267.8M
- Last Round
- $40.0M Series ENov 2013
About
TriVascular, now part of Endologix, develops endovascular aneurysm repair (EVAR) solutions for abdominal aortic aneurysms. They pioneered technologies for optimal patient outcomes in vascular disease, including the DETOUR System. Focused on disruptive innovation, clinical evidence, and physician training with VR.
Sign up to view funding chart
Create a free account to see funding visualizations and detailed round data.
Create Free AccountFunding History
Sign up to view funding details
Create a free account to see full funding history, valuations, and investor participation.
Create Free Account